532 related articles for article (PubMed ID: 1724640)
1. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.
Fleisch H
Drugs; 1991 Dec; 42(6):919-44. PubMed ID: 1724640
[TBL] [Abstract][Full Text] [Related]
2. Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.
Coukell AJ; Markham A
Drugs Aging; 1998 Feb; 12(2):149-68. PubMed ID: 9509293
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates: preclinical aspects and use in osteoporosis.
Fleisch HA
Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism.
Fleisch H
Recent Results Cancer Res; 1989; 116():1-28. PubMed ID: 2669065
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology and therapeutic utility of bisphosphonates.
Lourwood DL
Pharmacotherapy; 1998; 18(4):779-89. PubMed ID: 9692651
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates: the first 40 years.
Russell RG
Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
[TBL] [Abstract][Full Text] [Related]
7. Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Fitton A; McTavish D
Drugs; 1991 Feb; 41(2):289-318. PubMed ID: 1709854
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates and the treatment of bone disease in the elderly.
Johansen A; Stone M; Rawlinson F
Drugs Aging; 1996 Feb; 8(2):113-26. PubMed ID: 8845585
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates in the treatment of osteoporosis.
Bell NH; Johnson RH
Endocrine; 1997 Apr; 6(2):203-6. PubMed ID: 9225137
[TBL] [Abstract][Full Text] [Related]
10. New bisphosphonates in osteoporosis.
Fleisch H
Osteoporos Int; 1993; 3 Suppl 2():S15-22. PubMed ID: 8481594
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates: from the laboratory to the clinic and back again.
Russell RG; Rogers MJ
Bone; 1999 Jul; 25(1):97-106. PubMed ID: 10423031
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of action of the bisphosphonates.
Fleisch H
Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358
[TBL] [Abstract][Full Text] [Related]
13. The evolving role of bisphosphonates.
Theriault RL; Hortobagyi GN
Semin Oncol; 2001 Jun; 28(3):284-90. PubMed ID: 11402438
[TBL] [Abstract][Full Text] [Related]
14. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
Fleisch H
Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates in bone diseases.
Sparidans RW; Twiss IM; Talbot S
Pharm World Sci; 1998 Oct; 20(5):206-13. PubMed ID: 9820883
[TBL] [Abstract][Full Text] [Related]
16. New bisphosphonates in the treatment of bone diseases.
Gatti D; Adami S
Drugs Aging; 1999 Oct; 15(4):285-96. PubMed ID: 10582775
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates in the treatment of disorders of mineral metabolism.
Singer FR; Minoofar PN
Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials with bisphosphonates.
Lombardi A; Santora AC
Ann Ital Med Int; 1992; 7(3 Suppl):158S-165S. PubMed ID: 1297394
[TBL] [Abstract][Full Text] [Related]
19. Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates.
Heatley S
Int J Palliat Nurs; 2001 Jun; 7(6):301-2, 304-7. PubMed ID: 12066026
[TBL] [Abstract][Full Text] [Related]
20. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Plosker GL; Goa KL
Drugs; 1994 Jun; 47(6):945-82. PubMed ID: 7521833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]